Emily Chan
Internal Medicine · Brooklyn, NYNPI 1962085811
Payments from drug & device makers
Across 86 payments — averaging $104.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1K
- Amgen$1K
- AstraZeneca$1K
- GSK$766
- Madrigal Pharmaceuticals$691
- AbbVie$610
- plus $3K from 17 others
What the payments were for
- Food & beverage$8,995100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 11 | $1,341 |
| Amgen | 11 | $1,268 |
| AstraZeneca | 10 | $1,223 |
| GSK | 7 | $766 |
| Madrigal Pharmaceuticals | 5 | $691 |
| AbbVie | 5 | $610 |
| Alcon | 4 | $466 |
| Phathom Pharmaceuticals, Inc. | 3 | $400 |
| Novo Nordisk | 3 | $370 |
| Mallinckrodt Hospital Products Inc. | 6 | $282 |
| Exact Sciences | 2 | $226 |
| Bausch & Lomb Americas Inc. | 3 | $152 |
| Medtronic | 1 | $127 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Bayer | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| IBSA Pharma Inc. | 1 | $125 |
| Gilead | 1 | $125 |
| Angiodynamics, Inc. | 1 | $125 |
| Harrow Eye, LLC | 1 | $125 |
| Stryker | 3 | $81 |
| Tarsus Pharmaceuticals, Inc. | 3 | $63 |
| Dompe US, Inc. | 2 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,995 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 23 | $171 |
| Metoprolol Succinate | 13 | $91 |
| Metoprolol Tartrate | 12 | $81 |
| Metformin Hcl | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.